Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
Conditions: Shigellosis; Bacillary DysenteryIntervention: Biological: Shigella flexneri 2a InvaplexARSponsor: U.S. Army Medical Research and Materiel CommandNot yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2015 Category: Research Source Type: clinical trials
Safety of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a
Condition: ShigellosisInterventions: Biological: Flexyn2a; Biological: Placebo; Biological: Flexyn2a plus adjuvantSponsors: GlycoVaxyn AG; Wellcome Trust; Naval Medical Research CenterActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2015 Category: Research Source Type: clinical trials
Safety of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a
Condition: ShigellosisInterventions: Biological: Flexyn2a; Biological: Placebo; Biological: Flexyn2a plus adjuvantSponsors: GlycoVaxyn AG; Wellcome Trust; Naval Medical Research CenterRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2015 Category: Research Source Type: clinical trials